Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

Alain Bols; Carin C. van der Rijt; Carlos Freire de Oliveira; Enrico Cortesi; for the EPO-INT-47 Study Group; José A. Moreno-Nogueira; Paolo Pronzato; Peter Barrett-Lee; Peter J. Ostler; Ricardo Rosso

首页> 外文期刊>The oncologist >Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

【24h】

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

机译：Epoetin Alfa改善接受骨髓毒性化学疗法的乳腺癌患者的贫血和与贫血症有关的患者报告结果：欧洲多中心，随机，对照试验的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

>Purpose. To evaluate the effects of epoetin alfa on patient-reported outcomes (PROs) in patients with breast cancer receiving myelotoxic chemotherapy.

机译：>目的。为了评估依泊汀阿尔法对接受骨髓毒性化疗的乳腺癌患者的患者报告结局（PROs）的影响。

著录项

来源
《The oncologist》 |2010年第9期|共页
作者
Alain Bols; Carin C. van der Rijt; Carlos Freire de Oliveira; Enrico Cortesi; for the EPO-INT-47 Study Group; José A. Moreno-Nogueira; Paolo Pronzato; Peter Barrett-Lee; Peter J. Ostler; Ricardo Rosso;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. [J] . Pronzato P, Cortesi E, van der Rijt CC, The oncologist . 2010,第9期

机译：Epoetin alfa可改善接受骨髓毒性化疗的乳腺癌患者的贫血和与贫血相关的患者报告的预后：一项欧洲，多中心，随机对照试验的结果。
2. A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy [J] . Leyland-Jones Brian, Bondarenko Igor, Nemsadze Gia, Journal of Clinical Oncology . 2016,第11期

机译：依泊汀阿尔法与最佳治疗标准的随机，开放标签，多中心，III期研究，对接受标准化疗的贫血转移性乳腺癌患者
3. A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy [J] . Leyland-Jones Brian, Bondarenko Igor, Nemsadze Gia, Journal of Clinical Oncology . 2016,第11期

机译：随机开放标签，多中心，血液素Alfa对贫血患者的最佳护理标准，接受标准化疗
4. Rationale, Design and Preliminary Results of ROMEO (Rethink Organization to Improve Education and Outcomes) A Randomized Controlled Multicenter Trial of Group Care in the Management ofType 1 Diabetes [C] . M. Porta, M. Trent European Association for the Study of Diabetes . 2005

机译：Romeo（重新思考组织改善教育和结果）的基本理由，设计和初步结果，在1型糖尿病的术语中进行了随机对照的组织的多中心试验
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Epoetin Alfa Improves Anemia and Anemia-Related Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European Multicenter Randomized Controlled Trial [O] . Paolo Pronzato, Enrico Cortesi, Carin C. van der Rijt, 2010

机译：Epoetin Alfa改善接受骨髓毒性化学疗法的乳腺癌患者的贫血和与贫血症有关的患者报告结果：欧洲多中心随机对照试验的结果
7. Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. [O] . P. Pronzato, Enrico Cortesi, C.C. Van Der Rijt, 2010

机译：Epoetin alfa可改善接受骨髓毒性化疗的乳腺癌患者的贫血和与贫血相关的患者报告的预后：一项欧洲，多中心，随机对照试验的结果。
8. Randomized, Double Blind, Placebo controlled Trial of Neuroprotective Effects of Epoetin Alfa in Patients Receiving Adjuvant Chemotherapy for Breast Cancer [R] . Abraham, J. , Haut, M. , Marano, G. , 2005

机译：Epoetin alfa对乳腺癌辅助化疗患者的神经保护作用的随机，双盲，安慰剂对照试验

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

摘要

著录项

相似文献

相关主题

期刊订阅